Loading the knowledge graph…

Knowledge graph · Cancer

Malignant Neoplasm of Lung - Multiple Primary Sites

subtype

Identifier: CI-CAN-00001149
Entity page: /cancer/malignant-neoplasm-of-lung-multiple-primary-sites ↗
Edges: 11

Neighbours: 2 drugs9 trials
Drawn: 11 of 11 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Malignant Neoplasm of Lung - Multiple Primary Sites investigated in trials for …INVESTIGATED_IN_TRIALSderived2 of 2
→ investigated in trials for	Firmonertinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sintilimabmonoclonal antibody

Malignant Neoplasm of Lung - Multiple Primary Sites studied in …STUDIED_INderived9 of 9
→ studied in	NCT07819669NA · not yet recruiting Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung Cancer · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT06699979recruiting Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT06973499completed Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT05662553NA · unknown ENB Guided MWA Combined With VATS Versus Sequential Surgery for Synchronous Bilateral Multiple Primary Lung Nodules · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT04982900Phase 2 · unknown Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT05053802Phase 2 · recruiting Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT04840758Phase 1/Phase 2 · unknown Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT04326751unknown Evolution of Multiple Primary Lung Cancer (Evolution) · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →
→ studied in	NCT04026841Phase 2 · unknown The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density. · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	Malignant Neoplasm of Lung - Multiple Primary Sites	1	Observed	clinicaltrials	graph →

Malignant Neoplasm of Lung - Multiple Primary Sites studied in …STUDIED_INderived9 of 9

→ studied in

NCT07819669NA · not yet recruiting

Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung Cancer · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT06699979recruiting

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT06973499completed

Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT05662553NA · unknown

ENB Guided MWA Combined With VATS Versus Sequential Surgery for Synchronous Bilateral Multiple Primary Lung Nodules · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT04982900Phase 2 · unknown

Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT05053802Phase 2 · recruiting

Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT04840758Phase 1/Phase 2 · unknown

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT04326751unknown

Evolution of Multiple Primary Lung Cancer (Evolution) · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

→ studied in

NCT04026841Phase 2 · unknown

The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density. · condition mapped ALIAS · 9 trials mapped (3 active)

—

Malignant Neoplasm of Lung - Multiple Primary Sites

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains